TSXV:ENTG - Post Discussion
Post by
Betteryear2 on May 01, 2023 8:05pm
Posts $54.5 Million in Total Revenues V.ENTG
- Record net medical revenue of $17.4 million for 2022, representing 16% growth
- Entourage secured a 5% share of total sales, ranking them in the fourth spot of national pre-roll sales in 2022
- Upsized credit facility with LiUNA Pension Fund Central and Eastern Canada (“LPF”) improves liquidity position
TORONTO, May 01, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today its financial results for the fiscal year ended December 31, 2022.
“Attaining success in the cannabis market requires a two-fold approach, which involves producing high-quality products that foster customer loyalty while also implementing sound financial management practices that enable sustainable business growth," stated George Scorsis, CEO and Executive Chairman. "By adopting an asset-light model, we are focusing on investing in strategic partnerships and executing a strong business plan that prioritizes enhanced efficiency and cost accountability. This approach will enable the Company to focus on its core competencies, establishing a strong brand presence within the constantly evolving cannabis industry.”
Entourage Health Reports Fiscal Year 2022 Financial Results (globenewswire.com)
Be the first to comment on this post